Rheumatologic view of the rheumatoid foot

Clinical Orthopaedics and Related Research

Volumn 340, Issue , 1997, Pages 7-17

  Smyth, Charley J ^a   Janson, Robert W ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIRHEUMATIC AGENT; AURANOFIN; AZATHIOPRINE; BIOLOGICAL RESPONSE MODIFIER; CHOLINE MAGNESIUM TRISALICYLATE; CHOLINE SALICYLATE; CORTICOSTEROID; CYTOTOXIC AGENT; DICLOFENAC; DIFLUNISAL; ETODOLAC; FENOPROFEN; FENOPROFEN CALCIUM; FLURBIPROFEN; GOLD; HYDROXYCHLOROQUINE; IBUPROFEN; INDOMETACIN; KETOPROFEN; MECLOFENAMATE SODIUM; MECLOFENAMIC ACID; METHOTREXATE; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXAPROZIN; PENICILLAMINE; PIROXICAM; SALAZOSULFAPYRIDINE; SALICYLATE SODIUM; SALSALATE; SULINDAC; TOLMETIN; UNINDEXED DRUG;

ARTHRALGIA; CLINICAL FEATURE; CONFERENCE PAPER; DISABILITY; DISEASE COURSE; FOOT DISEASE; FOOT RADIOGRAPHY; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIDE EFFECT;

EID: 0030873464     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199707000-00003     Document Type: Conference Paper

References (41)

1. Alspaugh MA, Shoji H, Nomoyama M: A search for rheumatoid arthritis - associated nuclear antigen and Epstein-Barr virus specific antigens or genomes in tissues, and cells from patient with rheumatoid arthritis. Arthritis Rheum 26:712-720. 1983.
2. Alspaugh MA, Tan EM: Antibodies to cellular antigens in Sjögren's syndrome. J Clin Invest 55: 1067-1073, 1975.
3. Arnett FC: Histocompatibility typing in the rheumatic diseases. Diagnostic and prognostic implications. Rheum Dis Clin North Am 20:371-390, 1994.
4. Arnett FC, Edworthy S, Bloch DA. et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988.
5. Calabro JJ: A critical evaluation of the diagnostic-features of the feet in rheumatoid arthritis. Arthritis Rheum 5:19-29, 1962.
6. Cohen BJ, Buckley MM, Clewley JP, et al: Human parvovirus infection in early rheumatoid arthritis and inflammatory arthritis. Ann Rheum Dis 45:832-838, 1986.
7. da Silva JA: Heat-shock proteins: The missing link between hormonal and reproductive factors and rheumatoid arthritis? Ann Rheum Dis 50:735-739, 1991.
8. Felson DT, Anderson JJ, Meenan RF: The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. Arthritis Rheum 33:1449-1461, 1990.
9. Firestein GS: The immunopathogenesis of rheumatoid arthritis. Curr Opin Rheumatol 3:398-406, 1991.
10. Guerne PA, Weisman MH: Palindromic rheumatism: Part of or apart from the spectrum of rheumatoid arthritis. Am J Med 93:451-460, 1992.
11. Haase AT: Pathogenesis of lentivirus infections. Nature 322:130-136, 1986.
12. Haines RW, McDougall A: The anatomy of hallux valgus. J Bone Joint Surg 36B:272-293, 1954.
13. Harris Jr ED: Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 322:1277-1289, 1990.
14. Hench PS: The ameliorating effect of pregnancy on chronic atrophic (infectious arthritis), arthritis fibrositis and intermittent hydrarthrosis. Mayo Clin Proc 13:161-167, 1938.
15. Hench PS, Rosenberg EF: Palindromic rheumatism: a "new" often recurring disease of joints (arthritis, periarthritis, para-arthritis) apparently producing no articular residues - report of thirty-four cases; its relation to "angioneural arthrosis", "allergic rheumatism" and rheumatoid arthritis. Arch Intern Med 73:293-321, 1944.
16. Kaufmann SH: Heat-shock proteins: A link between rheumatoid arthritis and infection? Curr Opin Rheumatol 2:430-435, 1990.
17. Kellgren JH, Ball J: Tendon lesions in rheumatoid arthritis: A clinico-pathological study. Ann Rheum Dis 9:48-65, 1950.
18. Klippel JH: Winning the battle, losing the war? Another editorial about rheumatoid arthritis. J Rheumatol 17:1118-1122, 1990.
19. Kremer JM, Alarcon GS, Lightfoot RW, et al: Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. Arthritis Rheum 37:316-328, 1994.
20. Masi AT: Articular patterns in the early course of rheumatoid arthritis. Am J Med 75(Suppl 6A): 16-26, 1983.
21. McGuigan L, Burke D, Fleming A: Tarsal tunnel syndrome and peripheral neuropathy in rheumatoid arthritis. Ann Rheum Dis 42:128-131, 1983.
22. McKenna F: Clinical and laboratory assessment of outcome in rheumatoid arthritis. Br J Rheumatol 27(Suppl I):12-20, 1988.
23. Michelson J, Easley BS, Wigley FM, Hellmann D: Posterior tibial tendon dysfunction in rheumatoid arthritis. Foot Ankle Int 16:156-161, 1995.
24. Miescher PA, Huang YP, Zubler RH: New approaches to the treatment of rheumatoid arthritis. Springer Semin Immunopathol 10:251-262, 1988.
25. Paulus HE, Furst DE: Aspirin and Other Non-steroidal Anti-Inflammatory Drugs. In McCarty DJ (ed). Arthritis and Allied Conditions. Ed 11. Philadelphia, Lea & Febiger 1989.
26. Persellin RH: The effect of pregnancy on rheumatoid arthritis. Bull Rheum Dis 27:922-927, 1977.
27. Remmers EF, Sano H, Wilder RL: Platelet-derived growth factors and heparin-binding (fibroblast) growth factor in the synovial tissue pathology of rheumatoid arthritis. Semin Arthritis Rheum 21: 191-199, 1991.
28. Resnick D: Roentgen features of the rheumatoid mid- and hindfoot. J Can Assoc Radiol 27:99-107, 1976.
29. Schlegel SI, Paulus HE: Update on NSAID use in rheumatic diseases. Bull Rheum Dis 36:1-8, 1986.
30. Schreiber S, Schumacher HR, Cherian PV: Palindromic rheumatism with rheumatoid nodules: A case report with ultrastructural studies. Ann Rheum Dis 45:78-81, 1986.
31. Schumacher HR: Palindromic onset of rheumatoid arthritis. Clinical, synovial fluid, and biopsy studies. Arthritis Rheum 25:361-369, 1982.
32. Seltzer SE, Weissman BN, Braunstein EM, Adams DF, Thomas WH: Computed tomography of the hindfoot with rheumatoid arthritis. Arthritis Rheum 28:1234-1242, 1985.
33. Solomon G: Inflammatory Arthritis. In Jahss MH (ed). Disorders of the Foot and Ankle. Ed 2. Philadelphia, WB Saunders 1991.
34. Spiegel TM, Speigel JS: Rheumatoid arthritis in the foot and ankle - diagnosis, pathology and treatment. The relationship between foot and ankle deformity and disease duration in 50 patients. Foot Ankle 2:318-324, 1982.
35. Vainio S: The rheumatoid foot: A clinical study with pathological and roentgenological comments. Ann Chir Gynaecol Fenn 45(Suppl 1):1-107, 1956.
36. van Zeben D, Hazes JM, Vandenbroucke JP, Dijkmans BA, Cats A: Diminished incidence of severe rheumatoid arthritis associated with oral contraceptive use. Arthritis Rheum 33:1462-1465, 1990.
37. Walker AM, Funch D, Dreyer NA, et al: Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis. Arthritis Rheum 36:329-335, 1993.
38. Watson WC, Cremer MA, Wooley PH, Townes AS: Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a. Arthritis Rheum 29:1316-1321, 1986.
39. Weinblatt ME: Methotrexate in rheumatoid arthritis. Bull Rheum Dis 42:4-7, 1993.
40. Willkens RF: Prognostic staging for therapy of rheumatoid arthritis. Semin Arthritis Rheum 21:40-43, 1991.
41. Wolfe AM: The epidemiology of rheumatoid arthritis: A review. Bull Rheum Dis 19:518-529, 1968.